Rouan Sarah Kathryn
SEC CIK 1761366 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Dir | 4,390 | $59.9K | $2.28M | 9 | 2024-01-19 | 2026-01-02 |
Most active insiders at VKTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lian Brian | Pres, CEO, Dir | — | $14.01M |
| 2 | ZANTE GREG | CFO | — | $2.82M |
| 3 | Mancini Marianna | COO | — | $2.73M |
| 4 | Rowland Charles A Jr | Dir | — | $2.13M |
| 5 | FOEHR MATTHEW W | Dir | — | $561.8K |
| 6 | Aubuchon Neil William | Chief Commercial Off | $149.9K | — |
| 7 | Kelly-Gemmell Dorothy Elizabeth | Dir | — | — |
| 8 | Rouan Sarah Kathryn | Dir | — | — |
| 9 | MACARTNEY LAWSON | Dir | — | — |
| 10 | SINGLETON J MATTHEW | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-05 | 2026-01-02 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | A - Grant | $0.00 | +3,150 | 4,390 | +254% | $0 |
| A | 2025-04-08 | 2025-03-31 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | P - Purchase | $24.15 | +1,240 | 1,240 | New | +$29.9K |
| 2025-04-02 | 2025-03-31 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | P - Purchase | $24.15 | +1,240 | 1,240 | New | +$29.9K | |
| DT | 2024-10-25 | 2024-10-25 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | M - OptEx | $4.88 | +11.0K | 11.0K | New | +$53.7K |
| DT | 2024-10-25 | 2024-10-25 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | S - Sale+OE | $80.89 | -11.0K | 0 | -100% | -$889.8K |
| D | 2024-02-08 | 2024-02-08 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | M - OptEx | $8.32 | +25.0K | 25.0K | New | +$208.0K |
| D | 2024-02-08 | 2024-02-08 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | S - Sale+OE | $28.05 | -25.0K | 0 | -100% | -$701.2K |
| D | 2024-01-19 | 2024-01-19 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | S - Sale+OE | $23.05 | -30.0K | 0 | -100% | -$691.5K |
| D | 2024-01-19 | 2024-01-19 | VKTX | Viking Therapeutics, Inc. | Rouan Sarah Kathryn | Dir | M - OptEx | $8.32 | +30.0K | 30.0K | New | +$249.6K |
Purchase Sale Sale after option exercise All abbreviations